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Edited by Hans EklundAbstract Mammals express two active chitinases, chitotriosi-
dase and AMCase. Only AMCase displays an extremely acidic
pH optimum, consistent with its observed presence in the gastro-
intestinal tract. A structural model of AMCase reveals the
presence of a conserved histidine residue in the active site. Muta-
tional analyses and molecular dynamics simulations show that
His187 is responsible for the acidic optimum and suggest pH
dependent modulation of the reaction mechanism that is unique
to AMCases. Concluding, His187 is a crucial structural compo-
nent of the active site of AMCase and this unique feature may
serve as a lead for the development of speciﬁc inhibitors.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Chitinases are enzymes able to hydrolyze chitin, the linear
polymer of b-1,4-linked N-acetyl glucosamine (GlcNAc),
which is synthesized by a variety of lower organisms for struc-
tural purposes [1]. Despite the absence of endogenous chitin,
two active chitinases are expressed in mammals. Investigations
into the lysosomal storage disorder Gaucher disease serendip-
itously resulted in the identiﬁcation of the ﬁrst mammalian chi-
tinase, chitotriosidase [1–3]. Soon after the second chitinase
was discovered which due to its acidic pH optimum was named
acidic mammalian chitinase (AMCase) [4]. Both chitinases are
50 kDa proteins, consisting of a 39 kDa catalytic region sepa-
rated from a chitin-binding domain by a hinge region [4,5].
They both show considerable homology to chitinases from
lower organisms and are members of glycoside hydrolase fam-
ily 18 according to the classiﬁcation by Henrissat [6]. In man,
chitotriosidase is the sole chitinase present in the circulation,
consistent with its recently observed anti-fungal activity [7].
Despite this function in the innate immune system, in man a
frequent mutation occurs, rendering approximately 6% of
most ethnic groups completely deﬁcient in the enzyme [8].Abbreviations: AMCase, acidic mammalian chitinase; MD, molecular
dynamics; 4MU, 4-methylumbelliferyl
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doi:10.1016/j.febslet.2008.02.032Investigations into the tissue-speciﬁc expression of chitinase
mRNA and protein have revealed marked inter-species diﬀer-
ences between mice and man [9]. In both species AMCase is
expressed in the lung and gastro-intestinal tract. The occur-
rence of acidic chitinases in the stomach of Xenopus and Gallus
species suggests the protein to have evolved as a result of a
gene duplication early in tetrapod evolution [10].
A study of the kinetics of the enzyme revealed the protein to
be able to catalyze the hydrolysis of chitin substrates as well a
the reverse synthesizing reaction due to a phenomenon com-
mon to family 18 glycoside hydrolases known as transglycosy-
lation [11,12]. Importantly, AMCase has recently attracted
considerable attention due to a report linking the enzyme to
pathogenesis of asthma [13]. The protein was reported to be
elevated in a mouse model of bronchial asthma. Moreover,
inhibition with the transition-state analogue allosamidin ame-
liorated the Th2 driven, IL13 dependent inﬂammation, sug-
gesting chitinase activity to play a role in the disease, even in
the absence of chitin. Several genetic variants were later pro-
posed to be partly responsible for predisposition to the disease
[14]. The precise role of AMCase in immune-mediated diseases
is still far from clear since a later report suggested chitinase
activity to exert a beniﬁcial eﬀect by negatively regulating chi-
tin-induced tissue inﬁltration of innate immune cells associated
with allergy [15].
Crystal structures of several family 18 chitinases have been
solved, including that of chitotriosidase. The protein adopts a
(b/a)8 barrel fold, one of the most versatile folds known.
Despite its fairly compact structure, the molecule shows an
elongated cleft thought to be capable of binding long
chitin-oligomers, compatible with the enzymes presumed
endo-chitinolytic activity [16]. Co-crystallization experiments
of chitotriosidase with the chitin analogue allosamidin, a micro-
molar inhibitor, revealed extensive electrostatic interactions and
hydrogen bonding as well as hydrophobic stacking interactions
between aromatic residues and the hydrophobic acetyl moiety
of the chitin-analogue to allow for substrate binding [17].
The reaction mechanism of family 18 glycoside hydrolases
was previously shown to proceed via substrate assisted cataly-
sis, based on experiments performed on a bacterial chitinase,
Chitinase B [18]. The role of Asp117, located two amino acids
from the catalytic Glu119, in substrate binding is thought to be
pivotal, in that it changes conformation upon binding of the
substrate. pKa calculations combined with mutational analysis
performed on a homologous chitinase later indicated Asp115
and Asp117 to share a proton at all physiologically relevant
pHs in the native enzyme, with Asp117 capturing the protonblished by Elsevier B.V. All rights reserved.
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[19,20]. Subsequently, Glu119 is responsible for protonation
of the glycosidic bond, after which hydrolysis takes place.
No structural information has been reported on AMCase to
date. However, sequence homology within family 18 chitinases
suggests a common reactionmechanism. This study investigates
themolecular origin of the acidic optimumof acidicmammalian
chitinase by adopting a molecular modelling approach com-
bined with molecular dynamics (MD) simulations, revealing
adaptions necessary for functioning in an acidic environment.2. Materials and methods
2.1. Homology modelling and molecular dynamics
The models of human and murine AMCase were based on the crys-
tal structure of native chitotriosidase 1LQ0 (resolution 2.20 A˚). Initial
modelling of the AMCase structures was accomplished online usingFig. 1. Alignment of the 39 kDa domain of vertebrate chitotriosidase and AM
musculus; r – Rattus rattus; gg – Gallus gallus. Boxing is according to RISLEthe SWISSPROT server [21]. In order to construct a model of the
H187N mutant, the histidine at position 187 was converted into a
asparagine using the program Deepview [21]. Both the native and mod-
iﬁed models were subjected to energy minimalization in GROMACS
version 3.3.1 with the GROMOS96 forceﬁeld [22] using the steepest
decent method. The quality of the models based on a variety of stereo-
chemical parameters was determined by PROCHECK [23]. Surface
electrostatic potentials of the modelled structures were calculated
and visualized using Deepview [21]. MD was performed as described
in the supplemental information.2.2. Mutagenesis, recombinant protein expression and enzymatic assays
The H187N point mutation was introduced directly into the wild-
type murine AMCase cDNA in the expression plasmid, pcDNA3(1),
using the high ﬁdelity Quik-Change Site-Directed Mutagenesis Kit
(Stratagene, La Jolla, CA) following the manufacturers protocol.
Large-scale production and puriﬁcation of the wild-type and mutant
cDNA expression plasmids were performed using Promega Wizard
Plus Midiprep kits. Recombinant expression in COS-7 cells was
accomplished as described earlier [3]. For the enzyme activity assayCase. h – Homo sapiens; cf – Canis familiaris; b – Bos taurus; m –Mus
R similarity scoring.
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were incubated for 1 h at 37 C. The substrate mixtures contained
0.111 mM 4MU-deoxychitobiose and 1 mg/ml BSA in McIlvain buﬀer,
at diﬀerent pH. Reactions were stopped with 2.0 ml of 0.3 M glycine
NaOH buﬀer pH 10.6 and the formed 4MU (4-methylumbelliferyl)
was detected ﬂuorometrically (excitation at 445 nm; emission at
366 nm). Only less than 10% diﬀerence in the duplicates was allowed.
One unit (U) of activity is deﬁned as 1 nmol of substrate hydrolyzed
per hour.3. Results and discussion
3.1. Homology comparisons and overall AMCase structure
In order to gain insight into structure–function relationships
we aligned both chitinases of various species. The alignment
shown in Fig. 1 shows substantial overall conservation, in par-
ticular of the active site sequence, yet orthologue speciﬁc ami-
no acids exist at various positions. In order to assess their
importance in the catalytic mechanism we created models for
AMCase based on the published chitotriosidase structure
[16]. The overall structure shows high similarity with the exper-
imentally determined crystal structure of chitotriosidase. This
is reﬂected in a low root mean square deviation (RMSD) for
Ca atoms between the mouse AMCase model and chitotriosi-
dase structure of 0.54 A˚. PROCHECK detected no major devi-
ations from optimal geometry.3.2. Amino acid diﬀerences between AMCase and chitotriosidase
Amino acid substitutions resulting in increased protein sta-
bility or increased enzymatic activity at low pH should be dis-
tinguished. The majority of substitutions in AMCases
compared to chitotriosidase reside on the protein surface. This
suggests they are adaptions conferring stability rather than
adaptions directly modulating the reaction mechanism.
Indeed, calculation of the surface potential of both mouseFig. 2. Surface potential of murine AMCase, human chitotriosidase and hu
charge, respectively (±2.5 kT/e).and human AMCase shows that its substitutions result in a
predominantly negative charge at the surface, as compared
to chitotriosidase (Fig. 2). This most likely restricts intramolec-
ular repulsion as a consequence of excessive protonation at
low pH. Evolution of digestive lysozymes has followed a sim-
ilar pattern [24].
Additionally, since AMCase contains two additional cyste-
ines compared to chitotriosidase, a third disulﬁde bond most
likely enhances the fold integrity in an acidic environment.
Indirect evidence for this is provided by the observation that
AMCase shows a diﬀerent electrophoretic behaviour in the ab-
sence of a reducing agent, suggesting a diﬀerence in disulﬁde
bonding between the two mammalian chitinases [4].3.3. Inﬂuence of histidine 187
The mapping of sequence diﬀerences onto the modelled
structures revealed that only a single paralogue speciﬁc substi-
tution, His187, is located close to the active site. This histidine
is conserved in all AMCases (Fig. 1). Replacing His187 with an
asparagine in murine AMCase, the amino acid conserved at
this position in chitotriosidase, revealed a clear diﬀerence in
pH-dependent activity compared to wild-type enzyme. Strik-
ingly, activity at low pH is nearly abolished, wheras the
near-neutral activity is aﬀected far less (Fig. 3).
In order to elucidate the role of this residue, MD simulations
were performed on several systems: AMCase (both human and
murine) with fully protonated His187, AMCase with deproto-
nated His187, the mutant murine AMCase His187Asn and
chitotriosidase. All systems show considerable rigidity of sec-
ondary structure during the 10 ns runs, as shown by r.m.s. ﬂuc-
tuation (RMSF, a measure for ﬂexibility) of 0.05–0.25 nm,
consistent with the compact, highly stabilized structure of
the (b/a)8 barrel. As expected, in view of hydrolase activity,
the catalytic glutamic acid (Glu119), is accessible to solvent.man AMCase. Red and blue represent a negative and positive surface
Fig. 3. pH activity proﬁle of wild-type and mutagenized His187Asn
murine AMCase. Activity was measured with 4MU-deoxychitobioside
as substrate as described in Section 2.
Fig. 5. Location of His187 within the active site of mouse AMCase.
MD snapshot showing interactions between the buried (protonated)
His187, (deprotonated) Asp117, Asp115 and Tyr6. The solvated
catalytic Glu119 is also shown.
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tion between deprotonated Asp117 and protonated His187
that remains constant during the full 10 ns. This distance is
increased and ﬂuctuates in both the mutant and chitotriosi-
dase, suggesting that this strong interaction is absent in these
enzymes (Fig. 4). The results were highly similar simulating
both murine and human AMCase, suggesting the role of
His187 to be ubiquitous in both enzymes.
3.4. Acid pH optimum
A mechanistic explanation for the acid optimum and role of
His187 can be given based on the reaction mechanism postu-
lated earlier [20]. One of the pivotal steps in catalysis is the
rotation of Asp117, preceding binding of the substrate by
allowing formation of an H-bond with the N-acetyl moiety
of the chitinous substrate. This can only be achieved by disrup-
tion of the stabilized system in which Asp115 and Asp117
share a proton. Such a role can easily be envisioned for proton-
ated His187 based on the fact that it is located close to the
Asp115 carboxylate (Fig. 5).
For the observed pH optimum of mouse AMCase to be
explained by protonation of His187, the eﬀective pKa should
be dramatically decreased, however this is not without prece-
dent. pKa values of histidines are known to vary greatly
depending on their electrostatic environment [25]. In the caseFig. 4. Distances in time between Asp117 and His187/Asn187.
Distances were calculated for (4) systems: (1) murine AMCase with
protonated His187; (2) murine AMCase with deprotonated His187; (3)
His187Asn mutant murine AMCase; (4) chitotriosidase. The distances
plotted are between the Cc atoms of both amino acids. The values
shown are representative for each of three independent MD runs.of Bacillus circulans xylanase, for instance, the pKa value of
a histidine residue (His149) is estimated to be <2.3, based on
NMR titration experiments [26]. This is likely in part due to
the hydrophobic environment surrounding the residue. More
importantly perhaps, the histidine is inaccesible to solvent.
Similarly, in AMCase, the presence of several ‘‘acidic’’ hydro-
xyl (Tyr6) and carboxylic acid groups (Asp115 and Asp117) in
close vicinity may result in a change in eﬀective pKa of the his-
tidine (Fig. 5). Furthermore, visual inspection of the AMCase
simulations shows that His187 is inaccessible to bulk water in
both protonation states. The lack of stabilizing water mole-
cules close to His187 is likely to favor a neutral state at low
pH. Although our study renders proof for an important role
of His187 in the extremely acidic pH optimum of mouse AM-
Case, other structural features most likely also have an impact.
For example, the acidic activity of human AMCase is not as
pronounced as that of mouse AMCase, despite the presence
of His187 [4,12]. As the surface potential of mouse AMCase
is signiﬁcantly lower (Fig. 2), the loss of structural stability
at very low pH may limit the extreme acidic activity of human
AMCase. Thus concluding His187 represents a major diﬀer-
ence in the active site of AMCase compared to that of chitot-
riosidase. The amino acid allows activity at extremely low pH,
provided that the overall protein fold is stable at this extreme
condition. The unique His187 feature of AMCases may serve
as a lead for the development of speciﬁc inhibitors.
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